Omeros Corp. (OMER) Surged To A New High After FDA Breakthrough Designation

Omeros Corp. (OMER) announced Tuesday morning that the FDA has granted breakthrough therapy designation to OMS721 for the treatment of Immunoglobulin A (IgA) nephropathy, for the treatment of IgA nephropathy.

from RTT - Before the Bell http://ift.tt/2tliCxx
via IFTTT